Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate immune receptors in the gastrointestinal mucosa, collectively known as pattern recognition receptors (PRRs), are essential sensors that monitor the intestinal environment for microbial threats and tissue damage (Abreu, 2010, Nature Reviews Immunology). These receptors, which include Toll-like receptors (TLRs), NOD-like receptors (NLRs), and C-type lectin receptors (CLRs), are expressed by both intestinal epithelial cells and underlying immune cells such as macrophages and dendritic cells (Mogensen, 2009, Clinical Microbiology Reviews). Their primary function is to recognize conserved molecular motifs from pathogens (PAMPs) or damaged host cells (DAMPs), initiating signaling cascades that lead to the production of cytokines, chemokines, and antimicrobial peptides (Santaolalla & Abreu, 2012, Gastroenterology Research and Practice). In a healthy gut, these receptors maintain a delicate balance between tolerance to commensal bacteria and active defense against pathogens. Dysregulation of these innate sensing pathways is a major driver of chronic inflammatory conditions, most notably inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis (Hugot et al., 2001, Nature). Consequently, these receptors and their downstream signaling components are significant therapeutic targets, with various agonists and antagonists under investigation to either suppress pathological inflammation or boost protective mucosal immunity.
Modulation of innate immune signaling pathways, such as NF-κB and MAPK, through the activation or inhibition of specific pattern recognition receptors to regulate mucosal inflammation and restore intestinal barrier function.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate immune receptors in the gastrointestinal mucosa (GI-IIRs).